Mona Ashiya is a General Partner at OrbiMed. She previously worked in biotechnology equity research at J.P. Morgan.
At firms with a similar stage, sector and check size.





One email when Mona's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckMona Ashiya is a General Partner at OrbiMed. She previously worked in biotechnology equity research at J.P. Morgan.
Mona Ashiya invests through OrbiMed, which writes checks of $1M to $30M+ at seed, series a, series b.
Email [email protected], the firm's inbox for founders, and name Mona in the subject. A warm intro from a founder OrbiMed backed works better.
Harvard Business School; Global Alliance for TB Drug Development; member of biotechnology equity research team at J.P. Morgan.
Last updated 2026-10-15. Is this you? Ask for a correction.